CNS Form 4: Executive VP now holds 23,123 Cohen & Steers shares
Rhea-AI Filing Summary
Cohen & Steers, Inc. (CNS) executive vice president reported an automatic share-based accrual tied to company dividends. On 11/20/2025, the officer acquired 220 shares of common stock at a price of $0, reflecting dividend equivalent restricted stock units credited in connection with the issuer's fourth quarter 2025 dividend. These units accrued on unvested restricted stock units previously granted in June 2024 and January 2025. Following this transaction, the officer beneficially owned 23,123 shares of Cohen & Steers common stock, held directly.
Positive
- None.
Negative
- None.
FAQ
What did Cohen & Steers (CNS) report in this Form 4 filing?
The filing reports that an executive vice president of Cohen & Steers, Inc. (CNS) acquired 220 shares of common stock through dividend equivalent restricted stock units on 11/20/2025.
How many Cohen & Steers (CNS) shares does the executive now beneficially own?
After the reported transaction, the executive vice president beneficially owned 23,123 shares of Cohen & Steers common stock, held directly.
What is the nature of the 220 Cohen & Steers (CNS) shares acquired?
The 220 shares represent dividend equivalent restricted stock units credited in connection with the issuer's fourth quarter 2025 dividend on unvested restricted stock units granted in June 2024 and January 2025.
Was any cash paid for the 220 Cohen & Steers (CNS) shares reported?
No cash was paid; the 220 shares were acquired at a reported price of $0 as dividend equivalent restricted stock units.
What is the relationship of the reporting person to Cohen & Steers (CNS)?
The reporting person is an officer of Cohen & Steers, Inc., serving as Executive Vice President.
Does this Cohen & Steers (CNS) Form 4 involve derivative securities?
The disclosure table for derivative securities shows no reported derivative transactions; the reported acquisition relates to common stock via dividend equivalent restricted stock units.